XTL Biopharmaceuticals Ltd. XTLB
1.64 USD -0.02 (-1.20%)
At closeNov 12, 2026, 4:00 PM EST
1.63 -0.01 -0.61%
After hours · Nov 12, 4:00 PM ET
1.64 Day range 1.67
1.52 52-week range 5.64
- YTD
- -29.31%
- 1 year
- -57.73%
News
defenseworld.net Burning Rock Biotech (NASDAQ:BNR) and XTL Biopharmaceuticals (NASDAQ:XTLB) Critical Analysis Burning Rock Biotech (NASDAQ: BNR - Get Free Report) and XTL Biopharmaceuticals (NASDAQ: XTLB - Get Free Report) are both small-cap healthcare companies, but which is the better business? We will…
defenseworld.net XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB) Short Interest Update XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB - Get Free Report) was the recipient of a significant drop in short interest in the month of September. As of September 15th, there was short interest…
defenseworld.net DBV Technologies (NASDAQ:DBVT) versus XTL Biopharmaceuticals (NASDAQ:XTLB) Financial Analysis DBV Technologies (NASDAQ: DBVT - Get Free Report) and XTL Biopharmaceuticals (NASDAQ: XTLB - Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Tenon Medical (NASDAQ:TNON) stock rose 122.5% to $12.13 during Wednesday's pre-market session. The market value of their outstanding shares is at $3.6 million. As per the news, the Q2…
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session Gainers NextCure (NASDAQ:NXTC) shares rose 305.5% to $8.84 during Tuesday's pre-market session. The market value of their outstanding shares is at $7.8 million. Shuttle Pharmaceuticals (NASDAQ:SHPH)…- benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session Gainers Crinetics Pharmaceuticals (NASDAQ:CRNX) stock increased by 98.9% to $83.59 during Tuesday's pre-market session. The market value of their outstanding shares is at $4.4 billion. Bluejay…
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers Can Fite Biopharma (AMEX:CANF) shares rose 43.8% to $4.27 during Wednesday's regular session. The company's market cap stands at $6.3 million. Regencell Bioscience (NASDAQ:RGC) stock moved…
globenewswire.com XTL Completed the Acquisition of Psyga Bio Ltd. expands its IP portfolio to clinical-stage biopharmaceutical assets XTL Biopharmaceuticals (XTL) Completes the Acquisition of Psyga Bio and Establishes Psychedelic Biotechnology Platform At a…- benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session - benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com XTL Receives Nasdaq Noncompliance Letter Nasdaq informed the Company that this matter serves as an additional basis for delisting the Company's securities from Nasdaq and that the Nasdaq Hearings Panel (the "Panel") will consider this…
globenewswire.com XTL Announces Receipt of Staff Delist Determination from Nasdaq RAMAT GAN, ISRAEL, May 22, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE: XTLB. TA) (the "Company" or "XTL"), announced today that it has received a letter (the "Letter")…- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com Crude Oil Jumps 5%; Automatic Data Processing Posts Upbeat Earnings 
benzinga.com Dow Falls 100 Points; Brinker Earnings Beat Estimates US stocks lower, Dow falls 100 points. Energy shares up 1%, communication services down 0.7%. Brinker beats earnings, raises guidance. SAGT up 79%.
benzinga.com XTL Biopharmaceuticals Signs Agreement To Acquire Psyga Bio; Financial Terms Undisclosed XTL Biopharmaceuticals Ltd. (the "Company" or "XTL") announced today that it has entered into a definitive share purchase agreement (the "Purchase Agreement") to acquire 100% of the issued and…
globenewswire.com XTL Biopharmaceuticals to Acquire Psyga Bio, Establishing a Leading Psychedelic Biotechnology Platform with Advanced Clinical Pipeline, Licensed GMP Manufacturing and Proprietary Psilocybin Technologies Transaction Positions XTL at the Forefront of the Rapidly Expanding Global Psychedelic Therapeutics Market Following Major U.S. Regulatory Momentum
benzinga.com XTL Biopharma To Implement 1-For-4 Reverse ADS Split, Effective March 25, 2026 XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB) (TASE:XTLB.TA) (the "Company" or "XTL"), announced today that it plans to change the ratio of its American Depositary Shares ("ADSs") to its ordinary shares,…
globenewswire.com XTL Biopharmaceuticals Announces ADS Ratio Change RAMAT GAN, ISRAEL, March 20, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”), announced today that it plans to change the ratio of its…
globenewswire.com XTL Announces Receipt of Staff Delist Determination from Nasdaq and Plans to Request Hearing RAMAT GAN, ISRAEL, Feb. 27, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”), announced today that it has received a letter (the “Letter”)…
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session - benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- benzinga.com XTL Biopharmaceuticals Moves To Acquire 85% Of NeuroNOS And Has Already Scheduled A Shareholders Meeting For February 17, 2026 To Approve A Private Placement Of Up To $2M XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB) (TASE:XTLB.TA) (the "Company" or "XTL"), announced that it is working diligently to close the acquisition of 85% of the shares of NeuroNOS Ltd. from Beyond…
globenewswire.com XTL Update on Recent Developments RAMAT GAN, ISRAEL, Jan. 29, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”), announced that it is working diligently to close the…
benzinga.com XTL Biopharmaceuticals Receives Nasdaq Noncompliance Notice, Gets Time Through March 6 To Regain Compliance XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB) (TASE:XTLB.TA) (the "Company" or "XTL"), announced today that it has received a notification letter from The Listing Qualifications Department of The Nasdaq…
globenewswire.com XTL Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders' Equity Deficiency RAMAT GAN, ISRAEL, Jan. 23, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”), announced today that it has received a notification letter from…- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com Why Gelteq Shares Are Trading Higher By 50%; Here Are 20 Stocks Moving Premarket 
benzinga.com Beyond Air Deals Autism-Focused NeuroNOS To XTL For Equity, Future Payments Beyond Air announces sale of 85% of NeuroNOS to XTL Biopharmaceuticals, gaining cash, shares, and milestones, as XAIR stock jumps 165% premarket.- benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session
globenewswire.com XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership Unmatched scientific firepower: Two Nobel Laureates join Founder Prof. Haitham Amal, leading global autism researcher Critical unmet need: 1 in 31 U.S. children now affected, zero FDA-approved…- benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com Why Baidu Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket 
globenewswire.com XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency RAMAT GAN, ISRAEL, Dec. 24, 2025 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”), announced today that it has received a notification letter from…- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com XTL Biopharmaceuticals CFO Itay Weinstein Resigns; Niv Segal Appointed Successor, Effective December 11, 2025 On December 5, 2025, XTL Biopharmaceuticals Ltd. (the "Company") announced that effective December 11, 2025, Mr. Itay Weinstein resigned from his position as Chief Financial Officer of the Company.…
benzinga.com Why Vision Marine Technologies Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com Why Confluent Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket 
benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session - benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session - benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com Why Apogee Therapeutics Shares Are Trading Higher By 50%; Here Are 20 Stocks Moving Premarket - benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session